Alterations in [Met]- and [Leu]enkephalin and neurotensin content in basal ganglia induced by the long-term administration of dopamine agonist and antagonist drugs to rats |
| |
Authors: | Maria L. De Ceballos Susan Boyce Peter Jenner C. David Marsden |
| |
Affiliation: | MRC Movement Disorder Research Group, University Department of Neurology and Parkinson's Disease Society Research Centre, Institute of Psychiatry and King's College Hospital Medical School, Denmark Hill, London SE5, U.K. |
| |
Abstract: | Treatment of rats for 18 months with trifluoperazine increased [Met5]- and [Leu5]enkephalin and neurotensin content in striatum and nucleus accumbens. However, in substantia nigra the content of [Met5]enkephalin was decreased, [Leu5]enkephalin unchanged and that of neurotensin increased. Administration of L-DOPA plus carbidopa, bromocriptine or pergolide for 12 months decreased [Met5]enkephalin (except bromocriptine) and neurotensin, but not [Leu5]enkephalin, levels in striatum. L-DOPA decreased and bromocriptine increased neurotensin levels in substantia nigra. But neurotensin levels in nucleus accumbens were unaffected. |
| |
Keywords: | Neuroleptic drugs [Met5]enkephalin [Leu5]enkephalin, Neurotensin Long-term treatment |
本文献已被 ScienceDirect 等数据库收录! |
|